Acute kidney injury (AKI) is common in critically ill patients and carries severe complications
and a high risk of mortality [1]. Consequently, all preventive and protective strategies should …

Acute kidney injury (AKI) represents a common disorder in hospitalized patients, and its
incidence is rising at an alarming rate. Despite significant improvements in critical care and …

Over the past decade, large prospective cohort studies have repeatedly shown that novel
biomarkers are superior in performance to serum creatinine (SCr) in the early diagnosis and …

Acute kidney injury (AKI) is frequent in hospitalized critically ill patients and mortality
associated with AKI is largely unchanged over many decades. The new nomenclature, AKI …

Several new biomarkers of kidney damage have been characterized and are being
validated in clinical studies. These damage biomarkers complement existing conventional …

Despite recent developments in definition and staging, the diagnosis of (AKI) acute kidney
injury is still based on oliguria and/or an increase in serum creatinine [1]. Consequently …

Up to 40% of critically ill patients will develop an acute kidney injury (AKI)[1]. This renal
complication is associated with high morbidity, high short-term and longterm mortality and a …

Acute kidney injury (AKI) represents a major clinical problem, with rising incidence and high
mortality rate. The lack of early biomarkers has resulted in a delay in initiating therapies …

Acute kidney injury (AKI) is a common and serious medical condition associated with
significant increases in morbidity, mortality, and cost of care. Because of the high incidence …

Acute kidney injury (AKI) is a life-threatening illness that continues to have an in-hospital
mortality rate of patients with AKI ranges from 20% to 50% or greater, depending on …